Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2022, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2022-06-28
DOI
10.1155/2022/4831833
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dietary Polyphenols and Their Role in Oxidative Stress-Induced Human Diseases: Insights Into Protective Effects, Antioxidant Potentials and Mechanism(s) of Action
- (2022) Mithun Rudrapal et al. Frontiers in Pharmacology
- Bioactive Compounds of Citrus Fruits: A Review of Composition and Health Benefits of Carotenoids, Flavonoids, Limonoids, and Terpenes
- (2022) Ramesh Kumar Saini et al. Antioxidants
- Eupafolin inhibits breast cancer cell proliferation and induces apoptosis by inhibiting the PI3K/Akt/mTOR pathway
- (2021) Jiahui Wei et al. Oncology Letters
- Flavonoids’ Effects on Caenorhabditis elegans’ Longevity, Fat Accumulation, Stress Resistance and Gene Modulation Involve mTOR, SKN-1 and DAF-16
- (2021) María Alejandra Guerrero-Rubio et al. Antioxidants
- Epigenetic mechanisms in breast cancer therapy and resistance
- (2021) Liliana Garcia-Martinez et al. Nature Communications
- Oral silymarin formulation efficacy in management of AC-T protocol induced hepatotoxicity in breast cancer patients: A randomized, triple blind, placebo-controlled clinical trial
- (2021) Ghazal Sadat Askarpour Moezian et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Particle Therapy for Breast Cancer: Benefits and Challenges
- (2021) Wanrong Luo et al. Frontiers in Oncology
- Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes
- (2021) Lifen Cao et al. ANNALS OF SURGICAL ONCOLOGY
- Flavonoids and PI3K/Akt/mTOR signaling cascade: A potential crosstalk in anticancer treatment
- (2021) Badar Islam et al. CURRENT MEDICINAL CHEMISTRY
- Advances and challenges in cancer treatment and nutraceutical prevention: the possible role of dietary phenols in BRCA regulation
- (2021) Haroon Khan et al. PHYTOCHEMISTRY REVIEWS
- Amelioration of anxiety, depression, and chemotherapy related toxicity after crocin administration during chemotherapy of breast cancer: A double blind, randomized clinical trial
- (2021) Roham Salek et al. PHYTOTHERAPY RESEARCH
- Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
- (2021) Le Yu et al. SEMINARS IN CANCER BIOLOGY
- Potential Prospect of CDK4/6 Inhibitors in Triple-Negative Breast Cancer
- (2021) Ye Hu et al. Cancer Management and Research
- The Multifaceted Role of Flavonoids in Cancer Therapy: Leveraging Autophagy with a Double-Edged Sword
- (2021) Zhe Zhang et al. Antioxidants
- Bioactive PI3-kinase/Akt/mTOR Inhibitors in Targeted Lung Cancer Therapy
- (2021) Somayyeh Ghareghomi et al. Advanced Pharmaceutical Bulletin
- Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges
- (2020) J. Heil et al. ANNALS OF ONCOLOGY
- Apigenin as an anticancer agent
- (2020) Muhammad Imran et al. PHYTOTHERAPY RESEARCH
- Overcoming Endocrine Resistance in Breast Cancer
- (2020) Ariella B. Hanker et al. CANCER CELL
- Targeting epigenetics in cancer: therapeutic potential of flavonoids
- (2020) Haroon Khan et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Isolation of hesperetin - A flavonoid from Cordia sebestena flower extract through antioxidant assay guided method and its antibacterial, anticancer effect on cervical cancer via in vitro and in silico molecular docking studies
- (2020) Shanmugam Prakash et al. JOURNAL OF MOLECULAR STRUCTURE
- Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention
- (2020) Simona Izzo et al. Nutrients
- mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
- (2020) Zhilin Zou et al. Cell and Bioscience
- Experimental Approaches in Delineating mTOR Signaling
- (2020) Jiayi Qian et al. Genes
- New insights into the activities and toxicities of the old anticancer drug doxorubicin
- (2020) Sabina Y. van der Zanden et al. FEBS Journal
- Phytochemicals as PI3K/ Akt/ mTOR Inhibitors and Their Role in Breast Cancer Treatment
- (2020) Arunaksharan Narayanankutty Recent Patents on Anti-Cancer Drug Discovery
- Clinical Challenges in the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Literature Review
- (2020) Gayathri Nagaraj et al. ADVANCES IN THERAPY
- PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
- (2020) Daniela Miricescu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway
- (2020) Han-Tsang Wu et al. PHYTOMEDICINE
- mTOR Targeted Cancer Chemoprevention by Flavonoids
- (2020) Badar ul Islam et al. CURRENT MEDICINAL CHEMISTRY
- The Esophageal Cancer and the PI3K/AKT/mTOR signaling regulatory microRNAs; a novel marker for prognosis, and a possible target for immunotherapy
- (2019) Seyed Alireza Javadinia et al. CURRENT PHARMACEUTICAL DESIGN
- The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2
- (2019) Joanna R. Kovalski et al. MOLECULAR CELL
- Casticin-Induced Inhibition of Cell Growth and Survival Are Mediated through the Dual Modulation of Akt/mTOR Signaling Cascade
- (2019) Jong Lee et al. Cancers
- Immunotherapy and targeted therapy combinations in metastatic breast cancer
- (2019) Francisco J Esteva et al. LANCET ONCOLOGY
- Formononetin Enhances the Tumoricidal Effect of Everolimus in Breast Cancer MDA-MB-468 Cells by Suppressing the mTOR Pathway
- (2019) Qianmei Zhou et al. Evidence-based Complementary and Alternative Medicine
- Long-Term Side Effects of Adjuvant Therapy in Primary Breast Cancer Patients: Results of a Web-Based Survey
- (2019) Renate Haidinger et al. Breast Care
- Everolimus in hormone receptor-positive metastatic breast cancer: PIK3CA mutation H1047R was a potential efficacy biomarker in a retrospective study
- (2019) Zongbi Yi et al. BMC CANCER
- A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer
- (2019) Hye Joung Choi et al. GYNECOLOGIC ONCOLOGY
- Natural flavonoids for the prevention of colon cancer: A comprehensive review of preclinical and clinical studies
- (2019) Khashayar Afshari et al. JOURNAL OF CELLULAR PHYSIOLOGY
- HER2-enriched subtype and ERBB2 expression in HER2-positive breast cancer treated with dual HER2 blockade
- (2019) Aleix Prat et al. JNCI-Journal of the National Cancer Institute
- Genomic characterization of metastatic breast cancers
- (2019) François Bertucci et al. NATURE
- Long‐Term Effects of Breast Cancer Surgery, Treatment, and Survivor Care
- (2019) Dawn L. Lovelace et al. JOURNAL OF MIDWIFERY & WOMENS HEALTH
- The Role of Polyphenol (Flavonoids) Compounds in the Treatment of Cancer Cells
- (2019) Abu Hazafa et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- World Cancer Research Fund International: Continuous Update Project—systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk
- (2019) Doris S. M. Chan et al. CANCER CAUSES & CONTROL
- PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges
- (2019) Mohammad A. Khan et al. DRUG DISCOVERY TODAY
- Progress in Research on the Role of Flavonoids in Lung Cancer
- (2019) Oana Zanoaga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Is Dual mTORC1 and mTORC2 Therapeutic Blockade Clinically Feasible in Cancer?
- (2019) Nisha Unni et al. JAMA Oncology
- Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer
- (2019) Peter Schmid et al. JAMA Oncology
- Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
- (2019) Nedeljković et al. Cells
- Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines
- (2019) Arianna Bonizzi et al. Pharmaceutics
- Lupiwighteone induces caspase-dependent and -independent apoptosis on human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway
- (2019) Yeong-Seon Won et al. FOOD AND CHEMICAL TOXICOLOGY
- Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
- (2019) Mario Giuliano et al. LANCET ONCOLOGY
- Immunotherapy: A Challenge of Breast Cancer Treatment
- (2019) Marilina García-Aranda et al. Cancers
- Triple negative breast cancer: A thorough review of biomarkers
- (2019) Jesse Lopes da Silva et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer
- (2019) Atena Soleimani et al. GENE
- Circular RNAs: The star molecules in cancer
- (2019) Jianhong Liu et al. MOLECULAR ASPECTS OF MEDICINE
- Vanadium quercetin complex attenuates mammary cancer by regulating the P53, Akt/mTOR pathway and downregulates cellular proliferation correlated with increased apoptotic events
- (2018) Souvik Roy et al. BIOMETALS
- Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway
- (2018) Ruijuan Zhou et al. BMC Complementary and Alternative Medicine
- Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
- (2018) Ricardo L. B. Costa et al. BREAST CANCER RESEARCH AND TREATMENT
- Triple negative breast cancer in Asia: An insider’s view
- (2018) Chao Wang et al. CANCER TREATMENT REVIEWS
- BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy
- (2018) Erica L. Gornstein et al. Clinical Breast Cancer
- Targeted therapy for premenopausal women with HR+, HER2- advanced breast cancer: focus on special considerations and latest advances
- (2018) Aditya Bardia et al. CLINICAL CANCER RESEARCH
- Advances in the systemic treatment of triple-negative breast cancer
- (2018) J.M. Lebert et al. Current Oncology
- Neoadjuvant chemotherapy in breast cancer: more than just downsizing
- (2018) Marloes G M Derks et al. LANCET ONCOLOGY
- Quercetin suppresses breast cancer stem cells (CD44 + /CD24 − ) by inhibiting the PI3K/Akt/mTOR-signaling pathway
- (2018) Xiuli Li et al. LIFE SCIENCES
- Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction
- (2018) Lijun Jia et al. LIFE SCIENCES
- The mTOR–S6K pathway links growth signalling to DNA damage response by targeting RNF168
- (2018) Xiaoduo Xie et al. NATURE CELL BIOLOGY
- Basal-like Breast Cancers: From Pathology to Biology and Back Again
- (2018) Barry Gusterson et al. Stem Cell Reports
- Metastatic and triple-negative breast cancer: challenges and treatment options
- (2018) Sumayah Al-Mahmood et al. Drug Delivery and Translational Research
- Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells
- (2018) Hong-Wei Zhang et al. Scientific Reports
- Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer
- (2018) Jonathan T. Lei et al. Cell Reports
- Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis
- (2018) Michael M. Jonczyk et al. BREAST CANCER RESEARCH AND TREATMENT
- Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
- (2018) Zhiqiang Li et al. CANCER CELL
- Ubiquitination of Rheb governs growth factor-induced mTORC1 activation
- (2018) Lu Deng et al. CELL RESEARCH
- Therapeutic potential of targeting the Wnt/β-catenin pathway in the treatment of pancreatic cancer
- (2018) Seyed Alireza Javadinia et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Overexpression of cancer-testis antigen melanoma-associated antigen A1 in lung cancer: A novel biomarker for prognosis, and a possible target for immunotherapy
- (2018) Azar Fanipakdel et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Flavonoids in Cancer and Apoptosis
- (2018) Mariam Abotaleb et al. Cancers
- Androgen excess in breast cancer development: implications for prevention and treatment
- (2018) Giorgio Secreto et al. ENDOCRINE-RELATED CANCER
- Viral gene therapy for breast cancer: progress and challenges
- (2017) Antonela S. Asad et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling
- (2017) Bin Wang et al. NATURE
- Dietary flavonoid tangeretin induces reprogramming of epithelial to mesenchymal transition in prostate cancer cells by targeting the PI3K/Akt/mTOR signaling pathway
- (2017) Wen‑Bin Zhu et al. Oncology Letters
- Dietary flavonoids, luteolin and quercetin, inhibit invasion of cervical cancer by reduction of UBE2S through epithelial–mesenchymal transition signaling
- (2017) Tsung-Han Lin et al. Food & Function
- (−)-Epigallocatechin-3-Gallate Inhibits Colorectal Cancer Stem Cells by Suppressing Wnt/β-Catenin Pathway
- (2017) Yue Chen et al. Nutrients
- Mechanisms of resistance to irreversible epidermal growth factor receptor tyrosine kinase inhibitors and therapeutic strategies in non-small cell lung cancer
- (2017) Jing Xu et al. Oncotarget
- A novel ECG analog 4-(S)-(2,4,6-trimethylthiobenzyl)-epigallocatechin gallate selectively induces apoptosis of B16-F10 melanoma via activation of autophagy and ROS
- (2017) Jing Xie et al. Scientific Reports
- Dietary flavonoid fisetin for cancer prevention and treatment
- (2016) Rahul K. Lall et al. MOLECULAR NUTRITION & FOOD RESEARCH
- mTORC1 and mTORC2 in cancer and the tumor microenvironment
- (2016) L C Kim et al. ONCOGENE
- Inhibition of PI3K/Akt/mTOR signaling in PI3KR2-overexpressing colon cancer stem cells reduces tumor growth due to apoptosis
- (2016) Sugong Chen et al. Oncotarget
- Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade
- (2016) Amilcar Rivera Rivera et al. PLoS One
- Oral Ridaforolimus Plus Trastuzumab for Patients With HER2+ Trastuzumab-Refractory Metastatic Breast Cancer
- (2015) Milton Seiler et al. Clinical Breast Cancer
- Insights into the importance for designing curcumin-inspired anticancer agents by a prooxidant strategy: The case of diarylpentanoids
- (2015) Fang Dai et al. FREE RADICAL BIOLOGY AND MEDICINE
- Antitumor and immunomodulatory activity of genkwanin on colorectal cancer in the APC Min/+ mice
- (2015) Xue Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Resveratrol induces cell cycle arrest in human gastric cancer MGC803 cells via the PTEN-regulated PI3K/Akt signaling pathway
- (2015) XIAOPING JING et al. ONCOLOGY REPORTS
- A Potent Inhibitor of Phosphoinositide 3-Kinase (PI3K) and Mitogen Activated Protein (MAP) Kinase Signalling, Quercetin (3, 3', 4', 5, 7-Pentahydroxyflavone) Promotes Cell Death in Ultraviolet (UV)-B-Irradiated B16F10 Melanoma Cells
- (2015) Rather A. Rafiq et al. PLoS One
- Targeting Cancer Cells via the Reactive Oxygen Species-Mediated Unfolded Protein Response with a Novel Synthetic Polyphenol Conjugate
- (2014) S. Y. Shin et al. CLINICAL CANCER RESEARCH
- Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer
- (2014) Hui Jun Lim et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
- (2014) Fabrice André et al. LANCET ONCOLOGY
- Inhibition of Akt/mTOR Signaling by the Dietary Flavonoid Fisetin
- (2013) Deeba Syed et al. Anti-Cancer Agents in Medicinal Chemistry
- Energy deprivation by silibinin in colorectal cancer cells
- (2013) Komal Raina et al. Autophagy
- A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy
- (2013) Sara A. Hurvitz et al. BREAST CANCER RESEARCH AND TREATMENT
- Dealcoholated red wine induces autophagic and apoptotic cell death in an osteosarcoma cell line
- (2013) I. Tedesco et al. FOOD AND CHEMICAL TOXICOLOGY
- Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: A mechanism for cancer chemopreventive action
- (2013) Husain Yar Khan et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Phase II trial of temsirolimus in patients with metastatic breast cancer
- (2012) Gini F. Fleming et al. BREAST CANCER RESEARCH AND TREATMENT
- Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
- (2012) Thomas Bachelot et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- (2012) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Reversal of Tamoxifen Resistance (Hormone Resistance) by Addition of Sirolimus (mTOR Inhibitor) in Metastatic Breast Cancer
- (2011) G.S. Bhattacharvva et al. EUROPEAN JOURNAL OF CANCER
- Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch
- (2011) J. M. Haughian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started